Sichuan Kelun-Biotech prices 5,838,000-share H-share placement at HK$ 470.2

  • Sichuan Kelun-Biotech Biopharmaceutical agreed a private placement of 5,838,000 new H shares at HK$ 470.2 each.
  • Net proceeds expected at about HK$ 2.72 billion; net placing price about HK$ 466.5 per share.
  • New shares equal about 2.5% of existing issued share capital; about 2.44% on an enlarged basis.
  • Goldman Sachs, Citigroup, J.P. Morgan to place shares with at least six investors; completion subject to Hong Kong listing approval.
  • Proceeds earmarked mainly for R&D and clinical development; remainder for pipeline expansion, working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260708-12237253), on July 07, 2026, and is solely responsible for the information contained therein.